Scienture Holdings, Inc. (SCNX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Scienture reported revenue of $431,609, up 215.9% from $136,643 the year before. Net income was -$41.5M (a -9618.0% net margin), or -$67.50 per diluted share. Gross margin was 76.8% and operating margin was -9867.9%. Operating activities generated -$13.4M of cash, leaving -$13.4M of free cash flow. At fiscal year end, Scienture held $84.2M in total assets against $14.1M in total liabilities, including $6.7M of cash and equivalents.
Open the full interactive Scienture financials → Quarterly statements, key ratios, valuation history and price charts.
Scienture Key Stats
| Share Price | $3.24 |
|---|---|
| Market Cap | $5.1M |
| Revenue YoY Growth | +215.9% |
| 52-Week Range | $3.24 – $65.00 |
| Shares Outstanding | 1.6 million (basic, 2026 Q2) |
Scienture Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $17.1M | $9.9M | $11.4M | $8.3M | $136,643 | $431,609 |
| Cost of Goods Sold | $11.4M | $5.1M | $6.0M | $5.7M | $130,638 | $100,127 |
| Gross Profit | $5.7M | $4.7M | $5.5M | $2.6M | $6,005 | $331,482 |
| Operating Income | -$2.5M | -$5.3M | -$4.4M | -$7.3M | -$14.7M | -$42.6M |
| Pre-Tax Income | -$2.5M | -$5.3M | -$3.5M | -$17.8M | -$18.8M | -$43.5M |
| Income Tax | — | — | — | — | -$534,396 | -$2.0M |
| Net Income | -$2.5M | -$5.3M | -$3.5M | -$17.8M | $9.1M | -$41.5M |
| Diluted EPS | -$123.75 | -$243.75 | -$153.75 | -$187.25 | $62.00 | -$67.50 |
Scienture Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $590,050 | — | $56,325 | $343,639 |
| Net Income | -$3.6M | -$28.1M | -$3.4M | -$2.8M |
| Diluted EPS | -$4.75 | -$1.83 | -$2.00 | -$1.75 |
Scienture Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.9M | $3.1M | $1.1M | $151,908 | — | $6.7M |
| Current Assets | $9.2M | $4.4M | $2.1M | $2.8M | $6.3M | $7.9M |
| Total Assets | $9.8M | $5.8M | $3.7M | $12.5M | $104.9M | $84.2M |
| Current Liabilities | $842,238 | $926,026 | $2.1M | $11.6M | $7.9M | $2.7M |
| Total Long-Term Debt | — | — | — | $6.6M | $2.9M | — |
| Total Liabilities | $1.1M | $2.0M | $3.4M | $12.0M | $25.8M | $14.1M |
| Shareholders' Equity | $8.7M | $3.8M | $763,136 | $542,353 | $79.1M | $70.1M |
Scienture Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$2.2M | -$2.6M | -$1.5M | -$1.6M | -$14.3M | -$13.4M |
| Cash From Investing | -$37,505 | -$22,596 | -$427,845 | — | $27.6M | — |
| Cash From Financing | $5.3M | -$208,178 | -$35,171 | — | -$13.0M | $19.7M |
| Free Cash Flow | — | -$2.6M | -$1.5M | — | -$14.3M | -$13.4M |
| Dividends Paid | — | — | — | — | $14.9M | — |
Figures from Scienture's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Scienture financials page for every line item.
Scienture Company Profile
| Ticker | SCNX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Commack, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001382574 |
Frequently Asked Questions
What was Scienture's revenue in fiscal 2025?
Scienture (SCNX) reported revenue of $431,609 for fiscal 2025.
What is Scienture's annual revenue history?
Scienture's annual revenue by fiscal year: 2020: $17.1M; 2021: $9.9M; 2022: $11.4M; 2023: $8.3M; 2024: $136,643; 2025: $431,609.
What was Scienture's net income in fiscal 2025?
Scienture reported net income of -$41.5M for fiscal 2025.
What was Scienture's earnings per share (EPS) in fiscal 2025?
Scienture's diluted EPS was -$67.50 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Scienture generate in fiscal 2025?
Scienture generated -$13.4M of free cash flow in fiscal 2025.
What was Scienture's revenue last quarter?
In its most recent reported quarter (2026 Q2), Scienture reported revenue of $343,639.
How many shares of Scienture are outstanding?
Scienture reported a weighted average of 1.6 million basic shares outstanding in 2026 Q2.
What is Scienture's market cap?
Based on its latest closing price, Scienture (SCNX) has a market capitalization of about $5.1M.
When does Scienture's fiscal year end?
Scienture's fiscal year end, as registered with the SEC, is December 31.
Where is Scienture headquartered?
Scienture lists its business address in Commack, New York in its SEC filings.